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Abstract
Mice infected with Trypanosoma cruzi, the agent of Chagas disease, rapidly develop anemia and thrombocytopenia. These
effects are partially promoted by the parasite trans-sialidase (TS), which is shed in the blood and depletes sialic acid from the
platelets, inducing accelerated platelet clearance and causing thrombocytopenia during the acute phase of disease. Here,
we demonstrate that oral immunization of C57BL/6 mice with Phytomonas serpens, a phytoflagellate parasite that shares
common antigens with T. cruzi but has no TS activity, reduces parasite burden and prevents thrombocytopenia and
leukopenia. Immunization also reduces platelet loss after intraperitoneal injection of TS. In addition, passive transfer of
immune sera raised in mice against P. serpens prevented platelet clearance. Thus, oral exposure to P. serpens attenuates the
progression of thrombocytopenia induced by TS from T. cruzi. These findings are not only important for the understanding
of the pathogenesis of T. cruzi infection but also for developing novel approaches of intervention in Chagas disease.
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Introduction
The order Kinetoplastida is composed of flagellated unicellular
organisms, some of which live in soil or aquatic environments,
while others are parasites responsible for severe diseases in
humans, animals, and plants [1,2]. The combined number of
people infected by Kinetoplastida pathogens is estimated to be
over 20 million, resulting in various health problems and more
than 100,000 deaths each year. With half a billion people at risk,
mostly in tropical and subtropical areas, these parasites represent
an important global health problem with associated significant
economic burden [3]. Chagas disease is caused by Trypanosoma
cruzi, a Kinetoplastid transmitted by the feces of blood-feeding
triatomine insects [4–6]. The disease affects about 8 million people
in Latin America, of whom 30–40% have or will develop
neurologic manifestations [7], cardiomyopathy, and/or digestive
megasyndromes [8]. The variability in disease outcome has been
attributed to host responses and parasite heterogeneity [9].
T. cruzi infection in mice is associated with severe hematological
changes, including thrombocytopenia [10], neutropenia followed
by neutrophilia, and eosinophilia [11], which may contribute to
mortality. Marcondes and collaborators [12] reported that acute
T. cruzi infection is associated with anemia, thrombocytopenia,
leukopenia, and bone marrow hypoplasia and that these
alterations can be prevented by nifurtimox treatment. Similar
hematological alterations have also been described in experimental
African trypanosomiasis [13] and are common characteristics of
human immunodeficiency virus infection [14] and malaria [15].
The mechanism responsible for hematological alterations
observed in acute T. cruzi infection is not clearly understood.
Our previous studies revealed that nitric oxide (NO) does not play
a direct role in the development of anemia during T. cruzi
infection, but contributes together with TNF-a to oxidative pre-
hemolytic damage of erythrocytes in infected mice [16]. In
addition, IFN-induced p47GTPase (LRG-47) influences T. cruzi
control by simultaneously regulating macrophage microbicidal
activity and hemopoietic function [17].
Sialic acid in the surface of T. cruzi plays an important role in
the infectious process; however, T. cruzi is unable to synthesize
sialic acid. Instead, the parasite expresses trans-sialidase (TS),
which mediates transfer of sialic acid from host glycoconjugates to
parasite mucins [18–20]. T. cruzi TS depletes platelets with sialic
acid, increasing clearance and leading to thrombocytopenia
during acute infection [21].
T. cruzi exhibit immunological cross-reactivity with other
Kinetoplastida, including Leishmania spp. [22] and insect trypano-
somatids that belong to the genera Crithidia, Herpetomonas,
Leptomonas, and Blastocrithidia [23]. We showed that Phytomonas
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serpens, a tomato parasite also from the order Kinetoplastida,
shares antigens with T. cruzi [24] but has no TS activity [25].
These antigens are recognized by human sera and induce nitric
oxide-dependent protective immunity against experimental T.
cruzi infection in susceptible BALB/c mice [24,26,27]. Phytomonas
are etiologic agents of plant diseases found across southern Brazil,
North and Central Africa, and several European countries. These
trypanosomatids are found in plants of economic importance,
including cashew, coffee, cassava, coconut, and oil palms, and
infect edible fruits such as tomato, orange, guava, grape, and star
fruit, [28,29,30]. The parasite is transmitted to plants by the bite of
the coreid insect Phthia picta, as demonstrated by Jankevicius and
collaborators using controlled cage experiments [31].
There is no information about how the protective immunity
induced by P. serpens can modulate the biological activity of T. cruzi
TS on thrombocytopenia and leukopenia in mice during acute T.
cruzi infection. Here, we report that immunization with P. serpens
prevented clearance of platelets and leukocytes from the circula-
tion in T. cruzi-infected mice. Furthermore, antibodies raised by P.
serpens immunization attenuated the thrombocytopenia induced by
TS in vivo. Our results support the hypothesis that TS from T. cruzi
is the causal factor of the hematological alterations observed early
during infection and support the use of phytoflagellate trypano-
somatids as a safer source of immunogenic agents for treatment
and prevention of Chagas disease.
Materials and Methods
Ethics Statement
All animal procedures were performed in accordance with the
guidelines of the Brazilian Code for the Use of Laboratory
Animals: the protocols were approved by the Internal Scientific
Commission and the Ethics in Animal Experimentation Commit-
tee of Londrina State University (Approval Number: CEEA-
01.09).
Mice
Six- to 8-week-old C57BL/6 female and male mice were
supplied by the Multi-Institutional Center for Biological Investi-
gation, State University of Campinas, Brazil. Mice were main-
tained under standard conditions in the animal house of the
Department of Pathological Sciences, Centre for Biological
Sciences, State University of Londrina. Commercial rodent diet
(Nuvilab-CR1, Nuvital, Campo Moura˜o, Brazil) and sterilized
water were available ad libitum. Data analysis revealed no influence
of sex on experimental outcomes.
Parasites
T. cruzi Y [32], a generous gift from Dr. Paulo Arau´jo, State
University of Campinas, Brazil, was maintained by weekly
intraperitoneal (i.p.) inoculation of Swiss mice with 26105
trypomastigotes. To conduct our experiments, blood from
previously inoculated Swiss mice was obtained by cardiac
puncture with heparinized syringes.
P. serpens 15 T (see Figure S1) isolated from tomato fruit
(Lycopersicum esculentum) [31] was cultured in GYPMI medium
(glucose, yeast extract, peptone, and meat infusion) [24] at 28uC.
Immunization of Mice and Challenge with T. cruzi
For immunization of C57BL/6, living forms of P. serpens 15 T
collected during log phase growth [31] were washed 3 times by
centrifugation at 3000 g for 5 min in 15 mM PBS (phosphate-
buffered saline, pH 7.2) and administered by gavage (per os). Each
inoculum consisted of 26108 living parasites/0.1 mL in 15 mM
PBS, pH 7.2 given 4 times at 1-week intervals [24]. Seven days
after the last oral immunization with P. serpens, C57BL/6 mice
were infected i.p. with a non-lethal (102 or 56103 cells/animal) or
lethal (56105 cells/animal) doses of trypomastigotes. Control mice
received PBS alone.
Hematological Methods
Peripheral blood was collected from uninfected and infected
mice by cardiac puncture under ether anesthesia and counted by
standard methods [33]. Platelets were counted in peripheral blood
collected in polypropylene tubes containing 3.8% (w/v) sodium
citrate (citrate: blood ratio, 1:9) [21]. All manipulations were
carried out at room temperature. Platelets and leukocytes were
counted manually with a Neubauer hemocytometer. All blood
analysis and cell counts were performed 7, 12, or 21 days post-
infection (p.i.).
Bone Marrow Cell Harvest
Bone marrow cells were harvested by flushing the femoral shafts
with ice-cold PBS. The total number of megakaryocytes in cell
suspensions from uninfected and infected mice (12 days p.i.) was
determined by hemocytometer counting [12,34].
Monoclonal Antibody Anti-TS (mAb 39)
mAb 39 was selected from hybridomas prepared by fusion of
spleen mice immunized with membrane fraction of T. cruzi
trypomastigotes and p3U1 cells [36]. Antigen was prepared by
three cycles of freeze-thawing trypomastigotes in detergent-free
buffer and supernatant collection after centrifugation at 100,000 g.
Positive clones were screened by immunoblotting of total
trypomastigote lysates in SDS-PAGE sample buffer. Positive
clones were further cloned by limiting dilution and injected i.p.
into mice primed 24 h before with incomplete Freund Adjuvant.
Ascitic fluids were collected. Alternatively, antibodies were purified
by affinity chromatography with protein A Sepharose (GE)
following standard procedures.
Trans-sialidase (TS) Production and Purification
Recombinant T. cruzi TS lacking the carboxy-terminal repeats
was purified from Escherichia coli BL21 DE3 pLysS. The construct
was ligated into the NdeI and BamHI sites of pET 14b (Novagen)
using a fragment derived from pTS16 as described by Schenkman
and collaborators [35]. Expression was induced with 0.1 mM
IPTG for 20 h at 28uC. Cells collected by centrifugation, washed
in 20 mM Tris-HCl pH 8, resuspended in the same buffer
containing 0.1 M NaCl and a cocktail of protease inhibitors
(EDTA-free, Roche), and lysed by 3 passages in a French Press.
The extract was clarified by centrifugation at 10,000 g (30 min)
and separated on a Ni2+-agarose column (Qiagen). Unbound
material was washed with 100 volumes of 0.1 M NaCl, 50 mM
sodium phosphate, pH 8 and 10 mL of the same buffer, but at
pH 6, and eluted from the column in the same buffer containing
0.25 M imidazole. The eluted material was dialyzed against
20 mM Tris-HCl pH 8 and separated on a MonoQ column.
Fractions containing purified enzyme, as judged by SDS-PAGE,
were eluted between 0.15 and 0.2 M NaCl and stored at 4uC until
use. Native TS was purified from LLC-MK2 culture supernatants
by affinity chromatography on mAb 39 immobilized on CNBr-
Sepharose, as described previously [36].
Mouse Immune Sera
Ten C57BL/6 male mice were treated with 26108 living
culture of P. serpens (15 T strain) by gavage 4 times at 7-day
P. serpens Reduces TS-Induced Thrombocytopenia
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intervals. One week after the last inoculum, sera from immunized
mice were collected and used as hyperimmune sera against P.
serpens. All sera were tested by direct agglutination for P. serpens as
described previously [24].
TS Administration in Mice
Animals were injected i.p. with 50 mg enzyme in 0.1 mL PBS
for each experiment. We used a dose that is five times higher as
used in reference [21] because it was injected intraperitoneally.
Control mice received PBS alone. In 2 separate experiments, mice
received a single dose (0.1 mL) of immune sera anti-P. serpens
mixed with purified TS (50 mg) for 15 min at room temperature.
Serum samples obtained from naı¨ve mice were used as controls.
Twenty-four hours after injection, platelets and leukocytes were
counted.
Immunoblotting and ELISA
Parasite protein lysates were analyzed by SDS-PAGE. Resolved
proteins were electrophoretically transferred to nitrocellulose
membranes (Hybond C, Amersham Biosciences, England) for
western blotting. Membranes were blocked in 5% skim milk in
PBS for 16 h at 4uC or 2 h at 22uC. After washing with PBS/0.2%
Tween 20, membranes were incubated with diluted antibodies for
2 h at room temperature, then washed and incubated with
peroxidase-conjugated goat anti-rabbit or anti-mouse secondary
antibody (Sigma, 1:10000) for 1 h. Detection was performed
according to the manufacturer’s instructions. For ELISA, 96-well
plates were coated by incubating 50 mL native TS at 10 mg/mL in
0.1 M sodium bicarbonate (pH 8.5) for 12 h at 4uC. The protein
was removed and wells washed 3 times in PBS containing 0.05%
Tween 20 and incubated in the same buffer with 2% BSA and
2.5% skim milk for 1 h at 25uC. Antibodies diluted in blocking
solution were incubated 1 h at 25uC, washed 5 times with PBS,
0.05% Tween 20, and detected as described above using o-
phenylenediamine and H2O2.
Statistical Analysis
Statistical analysis was conducted using ANOVA with the
Bonferroni test. Comparisons between experimental groups were
performed using Student’s t-test. Values are presented as mean 6
SE. Differences were considered significant when p,0.05.
Results
T. cruzi-induced Transient Thrombocytopenia and
Leukopenia
We initially confirmed that T. cruzi infection caused transient
changes in platelets and leukocytes counts. As shown in figure 1,
C57BL/6 mice infected with 56103 blood T. cruzi trypomastigotes
developed thrombocytopenia (Figure 1A) and leukopenia
(Figure 1B) during the early stages of infection (day 12 p.i.), a
transient effect that lasted as long as acute phase of T. cruzi
infection remained. Platelet counts started to decrease after seven
days of T. cruzi infection (day 8 p.i = 67.566.66104/mL) and
values returned to normal by day 35 p.i (103.3611.76104/mL)
(data not shown). Interestingly, T. cruzi-infected mice developed
thrombocytopenia (day 12 p.i) when using different inoculum of
parasites (Figures 2 A and 2 B).
Oral Immunization with P. serpens Prevented Reduction
of Platelets and Leukocytes
Next, we tested whether immunization with P. serpens prevent
reduction in vivo of platelets and leukocytes in the host infected
with T. cruzi. For this, C57BL/6 mice previously immunized were
infected with trypomastigote forms of T. cruzi (105 cells/mouse,
lethal dose). Twelve days after infection, immunized mice
displayed a reduced decrease in platelets and leukocytes counts
(Figures 3 A and 3 B, p = 0.001) when compared with control
mice. Thus, platelets and leukocytes in infected mice appear to be
sensitive to oral exposure to P. serpens. Moreover, the immuniza-
tion reduced the parasitemia upon a T. cruzi challenge (Figure 4,
p,0.05). This reduction occurs in the early of infection and
protected mice to lethal dose of parasites (Figure 4C and
Figure 4D, p,0.05).
TS Reduces Platelet Blood Counts
When TS (50 mg) was injected intraperitonially in mice (same
route of T. cruzi infection), a strong reduction (around 50%) in the
normal platelet count was observed 24 h after the enzyme
injection (Figure 5 A, p,0.05). No effect was observed when TS
was heat-inactivated (see Figure S2). We did not observe changes
Figure 1. T. cruzi infection induces thrombocytopenia and
leukopenia transients in the early of infection. C5BL/6 mice were
infected with 56103 trypomastigotes (Y strain) via i.p. injection,
monitored for the development of thrombocytopenia and leukopenia,
and sacrificed at different time points post-T. cruzi infection. A: platelets
and B: leukocytes were counts from peripheral blood from uninfected
and infected mice. Values represent the mean 6 standard error and are
representative of three independent experiments, using 4–15 mice per
group. Results were analyzed by analysis of variance (ANOVA) followed
by Bonferroni multiple comparisons test. Asterisks indicates significant
differences (p,0.05) when compared with control group (uninfected).
doi:10.1371/journal.pone.0068299.g001
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in the leukocyte (Figure 5B) and megakaryocytes (Figure 5C)
counts of mice inoculated with TS.
Oral Exposure to P. serpens Reduces Thrombocytopenia
Induced by TS
To test whether oral immunization with P. serpens was able to
reduce the effects of TS on platelets, the enzyme was directly
injected in immunized animals. As shown in Figure 6, the
immunization prevented the effects of TS on platelets in mice.
Furthermore, the counts of megakaryocytes in the bone marrow
were essentially the same in all groups (Figure S3, p.0.05).
Hyperimmune Sera Against P. serpens Attenuates the
Effects of TS on Platelet Counts
Incubation of sera from mice immunized with P. serpens with TS
inhibited its thrombocytopenic effect on platelets (Figure 7 A,
p,0.05). Moreover, serum samples obtained from naı¨ve mice do
not inhibit the action of TS in vivo (Figure 7 B, p.0.05). By means
of immunoblotting analyses we showed that antibodies present in
the serum of P. serpens-immunized mice recognized polypeptides in
the cellular extract of P. serpens. However, antibodies from mice
Figure 2. T. cruzi infection induces thrombocytopenia and
leukopenia independent of the number of parasites used for
infection. Groups of C5BL/6 mice were infected with 102 or with 105
trypomastigotes (Y strain). A: platelets and B: leukocytes were counts
from peripheral blood from uninfected and infected mice. All cell
counts were performed 12 days p.i. Values represent the mean 6
standard error and are representative of two independent experiments,
using 6 mice per group. Comparisons between 2 experimental groups
were performed using Student’s t-test. Asterisks indicate significant
differences (p#0.001) when compared with control group (uninfected).
doi:10.1371/journal.pone.0068299.g002
Figure 3. Oral exposure to P. serpens attenuates thrombocyto-
penia and leukopenia induced by T. cruzi infection. C57BL/6 mice
received by gavage 26108 living P. serpens parasites four times at
weekly intervals and an i.p. challenge 1 week later with 105 blood
trypomastigotes by i.p. route. Whole blood samples were collected on
day 12 p.i. A: Platelets counts and B: Leukocytes counts. Values
represent the mean 6 standard error and are representative of three
independent experiments, using 8–12 mice per group. Results were
analyzed by analysis of variance (ANOVA) followed by Bonferroni
multiple comparisons test. Asterisks indicate significant differences
(p,0.001) between infected and uninfected controls. Double asterisks
indicate significant differences (p,0.05) between infected mice given
PBS (phosphate-buffered saline, pH 7.2) or immunized with P. serpens
(PS) prior to infection with T. cruzi.
doi:10.1371/journal.pone.0068299.g003
P. serpens Reduces TS-Induced Thrombocytopenia
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immunized with P. serpens did not recognize the purified native TS,
which was recognized by the monoclonal antibody anti-TS (mAb
39) in Western blots (Figure 8). Indeed, no effect of anti-P. serpens
sera in the enzymatic activity was found using sialyllactose as
substrates (data not shown).
Discussion
During the experimental infection of mice with T. cruzi, several
hematological abnormal parameters, including marked thrombo-
cytopenia and leukopenia, are observed [11,13,16,17,37]. These
alterations are transient [10] and can be prevented by trypanocidal
drugs [12], but there is still no suitable molecular explanation for
this effect. By using a model of infection with a T. cruzi Y strain in
C57BL/6 and BALB/c mice, which are prototype hosts for the
study of resistance and anemia in murine Chagas disease [34], we
could obtain in C57BL/6 mice (resistant type) a more severe
anemia compared to Swiss (susceptible mice) [37]. Ours results
demonstrate for the first time, that the previous immunization with
P. serpens, a tomato parasite, prevented the clearance of platelets
and leukocytes from circulation in T. cruzi-infected mice. In
addition, we found that a single i.p. injection (same route of
infection with T. cruzi) of TS into mice reduced the platelet count
by 50%, 24 h after TS injection. As described previously, TS has
the ability to disseminate systemically within the host: the blood
and bone marrow are the main sites where the enzyme may act to
reduce the platelet count [21]. More important, the immunization
with P. serpens reverted the effects of TS on platelets in mice. We
did not observe changes in the leukocyte and megakaryocytes
counts from mice inoculated with TS and previously immunized.
These data could indicate that TS does not cause deleterious
effects on the bone marrow and confirms the studies of Tribulatti
and co-workers [21].
T. cruzi is unable to synthesize sialic acids de novo [38], but
circumvents this limitation by expressing the enzyme TS, which is
able to directly transfer a(2, 3)-linked sialyl residues among the
glycoproteins or glycolipids [20]. TS is anchored to the membrane
by glycosylphosphatidylinositol and is shed into the surrounding
environment, and it is detected in the blood of infected animals
and human patients during the acute stage of the infection [39–
41]. In the C-terminus, the enzyme has tandem repetitive amino
acid units that allow it to persist in blood for at least 3 days [42],
allowing it to induce pathological disorders even far from the
infectious foci or to act on the blood cells [39]. Previous reports
indicated that TS from T. cruzi alters the platelet surface sialic acid
content, acting as a neuraminidase [39], which induces accelerated
clearance of the platelets leading to the thrombocytopenia
observed during acute Chagas disease [21]. Also, immunization
with culture forms of insect trypanosomatids has been shown to
induce partial protection against lethal T. cruzi inoculations [43].
In fact, we previously demonstrated that BALB/c mice immunized
with P. serpens and later challenged with a lethal inoculum of T.
cruzi trypomastigote forms show a significant decrease in
Figure 4. Oral exposure to P. serpens decreases parasitemia and
mortality in response to T. cruzi infection. C57BL/6 mice were
immunized with P. serpens (26108 living parasites per 0.1 mL PBS
administered by gavage) four times with one-week intervals. Seven
days after the last immunization mice were infected with Y strain of T.
cruzi, A: 102, B: 56103 and C: 105 trypomastigote forms, respectively.
Parasitemia were assessed over 30 days post infection. D: Survival of
immunized mice and infected with 105 (lethal dose). Data are
represented as mean 6 standard error represented of at last 10 mice
per group. Asterisks indicates significant differences (p,0.05). (?)
indicates that all animals died.
doi:10.1371/journal.pone.0068299.g004
P. serpens Reduces TS-Induced Thrombocytopenia
PLOS ONE | www.plosone.org 5 July 2013 | Volume 8 | Issue 7 | e68299
parasitemia and mortality [24]. As described previously, P. serpens
is highly immunogenic in mice and rabbits [24] and the sera from
patients with Chagas disease present a strong reactivity to P. serpens
antigens [26,44].
The results showing that hyperimmune sera against P. serpens
attenuated the effect of TS on platelets led us to ask whether this
inhibition was due to the presence of specific antibodies directed
against the enzymatic domain of TS since P. serpens shares
common antigens with T. cruzi [26,45]. However, the serum from
mice immunized with P. serpens do not recognize TS when tested
by Western blot or ELISA. Moreover, the monoclonal antibody
anti-TS (mAb 39) [36] do not recognize antigens in P. serpens. In
addition, no effect of sera in the enzymatic activity was found using
sialyllactose as substrates, while inhibit of platelet desialylation was
previously observed. These results suggest that the effect of P.
serpens immunization could be done through recognizing or
changing the substrate in vivo. Alternatively, the inhibition could
be consequence of changes in immune responses, as upon T. cruzi
infection TS elicits the formation of antibodies that inhibit its
activity (also called neutralizing and anti-catalytic domain), and
non-inhibitory antibodies (anti-lectin-like, anti-SAPA, and anti-
several epitopes on the proteins), also called cross-reacting
determinants [20]. Because of the cross reactive determinants
shared by TS with T. cruzi other molecules, v.g. SAPA, mainly
Figure 5. TS reduces blood platelets counts in naı¨ve C57BL/6
mice. Mice were inoculated i.p with 50 mg of recombinant TS. A:
platelet, B: leukocyte and C: megakariocyte counts were determined
24 h later. Values represent the mean 6 standard error and are
representative of two independent experiments; using 7–15 mice per
group Results were analyzed by analysis of variance (ANOVA) followed
by Bonferroni multiple comparisons test. Asterisks indicate significant
differences (p,0.05).
doi:10.1371/journal.pone.0068299.g005
Figure 6. Oral exposure to P. serpens restored the thrombocy-
topenia induced by TS. C57BL/6 Mice received by gavage 26108
living P. serpens parasites four times at weekly intervals and an i.p.
challenge 1 week the mice were inoculated i.p with 50 mg of
recombinant TS. Values represent the mean 6 standard error and are
representative of two independent experiments, using 7–10 mice per
group. Results were analyzed by analysis of variance (ANOVA) followed
by Bonferroni multiple comparisons test. PBS (phosphate-buffered
saline, pH 7.2) and PS (immunized with P. serpens). Asterisks indicate
significant differences (p#0.001) when compared with control group
(uninfected).
doi:10.1371/journal.pone.0068299.g006
P. serpens Reduces TS-Induced Thrombocytopenia
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situated on the non-catalytic portion of the TS, it is conceivable
that these highly conserved sequences are present also in P. serpens.
Indeed, sialidases are highly conserved in insect trypanosomatids
and also in some bacteria [46]. Therefore, antibodies to P. serpens
cross-reactive to the non-catalytic portion of TS could neutralize
the injected TS, which would prevent its activity on the platelets.
However, the frequency and of such antibodies in the polyclonal P.
serpens immune serum could be low and prevent their direct
detection. We confirmed the presence of anti-TS antibodies on
day 12 after infection, which might contribute to decrease the
thrombocytopenia. For example, mice infected with T. cruzi
produce antibodies that are able to neutralize TS activity only if
mice survive the acute phase of infection [40]. Accordingly, the
sera from chronic Chagasic patients and rodents infected with T.
cruzi can inhibit TS by recognizing its amino-terminal and
catalytic domain [41]. Another possibility is that hyperimmune
P. serpens sera affect TS clearance preventing platelet desialylation.
Moreover, the reduction in the clearance of platelets from
circulation in T. cruzi-infected mice and previously immunized
with P. serpens, can be partly explained if we consider a wide
distribution of the carbohydrate epitopes galactosyl a(1–3)
galactose in P. serpens, as described by Gazzinelli and collaborators
[47]. In fact, potent inhibitors of T. cruzi propagation in vitro and
in vivo IN humans are antibodies directed against TS or the a-
galactosyl residues of trypanosomal mucins [48]. Therefore,
antibodies to carbohydrate epitopes present in the sera of animals
Figure 7. Sera of P. serpens-immunized mice inhibit the activity
of TS on platelets. The mice were injected i.p. with 50 mg of TS in
0.1 ml previously mixed with immune serum A or with normal serum B.
A third group of mice received only PBS instead of TS. Platelet counts
were determined 24 h later. Values represent the mean 6 standard
error and are representative of two independent experiments, using 4–
7 mice per group. Results were analyzed by analysis of variance
(ANOVA) followed by Bonferroni multiple comparisons test. Asterisks
indicate significant differences (p,0.05) of samples compared with PBS.
doi:10.1371/journal.pone.0068299.g007
Figure 8. Mice immunized with P. serpens lack antibodies to TS.
A. ELISA of plates coated with recombinant TS using control mice serum
or sera immunized with P. serpens, followed by infection with T. cruzi. B.
Immunoblotting showing the polypeptides recognized by hyperim-
mune sera anti-P. serpens detected in the whole cellular extract from P.
serpens. Alternatively, the TS was also revealed using anti-TS antibody
(mAb 39). Number on the left indicate the apparent molecular mass of
protein standards expressed in kDa.
doi:10.1371/journal.pone.0068299.g008
P. serpens Reduces TS-Induced Thrombocytopenia
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immunized with P. serpens could promote a decrease of activity of
TS on platelets.
In conclusion, our observations demonstrate an effect of P.
serpens immunization of the action of TS on platelets during T. cruzi
infection. Further elucidation of the mechanism by which the P.
serpens affect TS can provide new tools to understand the
progression of Chagas disease.
Supporting Information
Figure S1 Tomatoes (Lycopersicum esculentum) infect-
ed with Phytomonas serpens. A and B. (A) Tomatoes
infected. (B) Living culture flagellates forms of P. serpens (original
magnification 400 X). Arrows indicate local infection on the fruit.
(TIF)
Figure S2 Heat-inactivated TS does not modify the life
span of platelets. C57BL/6 mice were inoculated i.p. with
50 mg of recombinant TS heat-inactivated. Platelets counts were
determined 24 h later. Values represent the mean 6 standard
error and are representative of two independent experiments;
using 4 mice per group Results were analyzed by analysis of
variance (ANOVA) followed by Bonferroni multiple comparisons
test. Asterisks indicate significant differences (p,0.05) when
compared with control group (PBS).
(TIF)
Figure S3 Oral exposure to P. serpens does not induce
alterations in megakariocyte counts. The mice received by
gavage 26108 living P. serpens parasites four times at weekly
intervals and an i.p. 1 week later the mice were inoculated i.p. with
50 mg of recombinant TS. Megakariocyte counts were determined
24 h later. Values represent the mean 6 standard error and are
representative of two independent experiments, using 12 mice per
group. Results were analyzed by analysis of variance (ANOVA)
followed by Bonferroni multiple comparisons test. PBS (phos-
phate-buffered saline, pH 7.2) and PS (immunized with P. serpens).
(TIF)
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